Canertinib T6136
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
CAS nr:
267243-28-7
Purity:
98%
Molecular Weight:
485,94
SMILES:
C=CC(=O)Nc1c(cc2c(c1)c(ncn2)Nc1cc(c(cc1)F)Cl)OCCCN1CCOCC1
Formula:
C24H25ClFN5O3
Pathway:
JAK/STAT signaling,Tyrosine Kinase/Adaptors,Angiogenesis
Target:
EGFR,EGFR,EGFR
